Results 221 to 230 of about 10,168,516 (390)

The Role of Vitamin D in Autoimmune Diseases. [PDF]

open access: yesInt J Mol Sci
Vincenzi F   +3 more
europepmc   +1 more source

T cell functions by concanavalin A-induced suppressor T cell function test and autologous mixed lymphocyte reaction in various autoimmune diseases

open access: diamond, 1984
Masahide Takai   +7 more
openalex   +2 more sources

The coexistence of autoimmune rheumatic diseases and thymomas [PDF]

open access: gold, 2017
Ying Jiang   +3 more
openalex   +1 more source

Evaluation of a novel EHR sidecar application to display RA clinical outcomes during clinic visits: results of a stepped‐wedge cluster randomized pragmatic trial

open access: yesArthritis Care &Research, Accepted Article.
Objective We developed a novel EHR sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient‐facing graphical interface designed for use during outpatient visits (“RA PRO dashboard”).
Gabriela Schmajuk   +16 more
wiley   +1 more source

Prevalence and Severity of Sleep Disorders in Patients With Mycosis Fungoides: A Case-Control Study

open access: yesJournal of Skin Cancer
Ahmad Vafaeian   +6 more
doaj   +1 more source

COVID‐19 Vaccination is not Associated with the Development of Idiopathic Inflammatory Myositis in U.S. Veterans

open access: yesArthritis Care &Research, Accepted Article.
Objective Several case reports have proposed a potential association between COVID‐19 vaccination and the subsequent development of idiopathic inflammatory myositis (IIM). This study examined prior COVID‐19 vaccination in US Veterans who developed new‐onset IIM compared to those without new‐onset IIM.
Caleb Hernández   +10 more
wiley   +1 more source

Artificial intelligence for autoimmune diseases. [PDF]

open access: yesNPJ Digit Med
Mahajan A   +4 more
europepmc   +1 more source

Bone marrow transplantation in the treatment of autoimmune diseases [PDF]

open access: bronze, 1997
Alan Tyndall, Aloïs Gratwohl
openalex   +1 more source

MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY

open access: yesArthritis Care &Research, Accepted Article.
Objective Mycophenolate Mofetil (MMF) use in limited cutaneous systemic sclerosis (lcSSc) is relatively uncommon due to the lower fibrotic burden and the predominance of the vascular complications. In vitro observations and clinical data from transplanted patients suggest a protective effect of MMF on endothelial function.
Enrico De Lorenzis   +77 more
wiley   +1 more source

Home - About - Disclaimer - Privacy